• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用双膦酸盐的联合及序贯疗法。]

[Combination and sequential therapy using bisphosphonates.].

作者信息

Okazaki Ryo

机构信息

Third Department of Medicine, Teikyo University Chiba Medical Center, Japan.

出版信息

Clin Calcium. 2017;27(2):263-271.

PMID:28123129
Abstract

Bisphosphonates have been explored possible combination and/or sequential use with other anti-osteoporotic medications including PTH. Besides with vitamin D(metabolites), combination treatment had been uncommon mainly because there had not been enough anti-fracture evidence. PTH, which can only be used for a certain period over lifetime, requires other anti-osteoporotic medications after and/or before its use. Bisphosphonates have been tried with PTH in various sequential and/or combination ways. Various combination and/or sequential therapy using bisphosphonates will be reviewed in this article.

摘要

双膦酸盐已被探索与包括甲状旁腺激素(PTH)在内的其他抗骨质疏松药物联合使用和/或序贯使用。除了与维生素D(代谢物)联合外,联合治疗并不常见,主要是因为缺乏足够的抗骨折证据。PTH在一生中只能使用一定时间,在其使用前后需要其他抗骨质疏松药物。双膦酸盐已尝试与PTH以各种序贯和/或联合方式使用。本文将综述使用双膦酸盐的各种联合和/或序贯疗法。

相似文献

1
[Combination and sequential therapy using bisphosphonates.].[使用双膦酸盐的联合及序贯疗法。]
Clin Calcium. 2017;27(2):263-271.
2
Using Osteoporosis Therapies in Combination.联合使用骨质疏松症疗法。
Curr Osteoporos Rep. 2017 Aug;15(4):343-352. doi: 10.1007/s11914-017-0376-x.
3
[The influence of bisphosphonates on fracture healing].[双膦酸盐对骨折愈合的影响]
Orthopade. 2007 Feb;36(2):136-40. doi: 10.1007/s00132-006-1036-5.
4
Use of teriparatide in osteoporotic fracture patients.特立帕肽在骨质疏松性骨折患者中的应用。
Injury. 2016 Jan;47 Suppl 1:S36-8. doi: 10.1016/S0020-1383(16)30009-2.
5
[Efficacy and safety of long-term bisphosphonate treatment for osteoporosis.].[长期双膦酸盐治疗骨质疏松症的疗效与安全性。]
Clin Calcium. 2017;27(2):239-246.
6
Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.抗骨质疏松药物预防继发性脆性骨折的有效性:系统评价和荟萃分析。
Osteoporos Int. 2017 Dec;28(12):3289-3300. doi: 10.1007/s00198-017-4175-0. Epub 2017 Aug 2.
7
Management of postmenopausal osteoporosis and the prevention of fractures.绝经后骨质疏松症的管理及骨折预防
Panminerva Med. 2014 Jun;56(2):115-31. Epub 2014 Jun 19.
8
Fracture repair: general aspects and influence of osteoporosis and anti-osteoporosis treatment.骨折修复:一般情况以及骨质疏松症和抗骨质疏松治疗的影响
Injury. 2016 Jan;47 Suppl 1:S10-4. doi: 10.1016/S0020-1383(16)30003-1.
9
How do bisphosphonates affect fracture healing?双膦酸盐如何影响骨折愈合?
Injury. 2016 Jan;47 Suppl 1(0 1):S65-8. doi: 10.1016/S0020-1383(16)30015-8.
10
Duration of anti-resorptive therapy for osteoporosis.骨质疏松症抗吸收治疗的疗程
Endocrine. 2016 Feb;51(2):222-4. doi: 10.1007/s12020-015-0748-x. Epub 2015 Oct 3.